Structural Complementation Bioluminescence for Protein Interaction Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing technologies lack sensitive tools to detect and monitor molecular interactions under physiological conditions, particularly at normal expression levels, necessitating improved methods for high-sensitivity detection of protein interactions.

Innovation Solution

The assembly of bioluminescent complexes from non-luminescent peptides and polypeptides through structural complementation, which emit light upon association, allowing for the detection of molecular interactions by correlating them to the formation of these complexes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional detection methods are used to monitor molecular interactions, then the detection can be performed under standard conditions, but the sensitivity is insufficient for detecting interactions at normal expression levels

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddetection system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The bioluminescent protein is divided into two separate non-luminescent fragments that do not exhibit bioluminescent activity individually. These fragments are designed to be structurally complementary and only reconstitute the functional bioluminescent complex when they interact with their target molecules, thereby achieving high-sensitivity detection through the reconstituted signal while keeping individual components simple and non-luminescent

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The non-luminescent bioluminescent protein fragments serve as intermediary elements that mediate the detection of molecular interactions. When the fragments bind to their respective target molecules, they are brought into proximity and orientation that enables reconstitution of the bioluminescent active site, converting the molecular interaction event into a detectable optical signal

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If bioluminescent proteins are used directly for detection, then high sensitivity is achieved, but the complexity of maintaining bioluminescent activity increases

Engineering Contradiction:
Improvedetection sensitivityVSAvoidprotein expression and stability
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The bioluminescent protein is segmented into two stable, non-luminescent fragments that can be expressed independently without the complexity of maintaining full bioluminescent activity. This segmentation allows each fragment to be more stable and easier to manufacture, while the bioluminescent function is only reconstituted when both fragments are present and properly oriented through their molecular interactions

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The bioluminescent active site is effectively extracted and distributed between two separate fragments. By removing the ability of individual fragments to exhibit bioluminescence and retaining only the structural and binding functions, the system simplifies the expression and stability requirements for each component while preserving the high-sensitivity detection capability through reconstituted bioluminescence upon target interaction

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables high-sensitivity detection of molecular interactions, providing a bioluminescent signal proportional to the strength and stability of the interactions, thus enhancing the monitoring of protein interactions under physiological conditions.

Implementation Method 1

bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide

Methodology Applied
Scientific EffectBioluminescence: Bioluminescence

Data Source

PatentUS12367513B2Activation of bioluminescence by structural complementation
Publication Date: 2025.07.22 PROMEGA CORP
  • US12367513B2 patent drawing
  • US12367513B2 patent drawing
  • US12367513B2 patent drawing

AI summary

Provided herein are compositions and methods for the assembly of a bioluminescent complex from two or more non-luminescent (e.g., substantially non-luminescent) peptide and/or polypeptide units. In particular, bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide.